Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Development of vaccines based on formulations containing nonionic block copolymers

R N Brey1

  • 1Vaxcel, Inc., Norcross, Georgia 30071, USA.

Pharmaceutical Biotechnology
|January 1, 1995
PubMed
Summary

Nonionic block copolymers effectively enhance antibody responses against various antigens. These polymer formulations show promise for developing new vaccines, including those for malaria and pneumococcal diseases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Targeting polymerised liposome vaccine carriers to intestinal M cells.

Vaccine·2001
Same author

Phase I clinical trials of aroA aroD and aroA aroD htrA attenuated S. typhi vaccines; effect of formulation on safety and immunogenicity.

Vaccine·2000
Same author

Copolymer adjuvants.

Advances in experimental medicine and biology·1995
Same author

Oral delivery of antigens in live bacterial vectors.

Advances in experimental medicine and biology·1991
Same author

Oral Salmonella typhimurium vaccine expressing circumsporozoite protein protects against malaria.

Science (New York, N.Y.)·1988
Same author

Cloning of multiple genes involved with cobalamin (Vitamin B12) biosynthesis in Bacillus megaterium.

Journal of bacteriology·1986

Area of Science:

  • Immunology
  • Polymer Science
  • Vaccinology

Background:

  • Nonionic block copolymers are explored for vaccine adjuvant applications.
  • Previous studies evaluated polymers in aqueous buffers and emulsions.
  • Formulations have been tested in malaria and pneumococcal vaccine models.

Purpose of the Study:

  • To assess the efficacy of nonionic block copolymers as vaccine adjuvants.
  • To investigate the impact of copolymer formulations on antibody isotype development.
  • To explore the potential for clinical evaluation of these adjuvant systems.

Main Methods:

  • Evaluation of nonionic block copolymers in various delivery formats (aqueous buffer, oil-in-water, water-in-oil emulsions).
  • Assessment of antibody responses, including IgG2a subclass, in vaccine models.
  • Investigation of T-cell subset stimulation and potential for CTL induction.

Main Results:

  • Nonionic block copolymers effectively enhance antibody responses to viral, parasitic, and bacterial antigens.
  • Specific formulations induced protective antibodies in malaria and pneumococcal models, associated with IgG2a.
  • Copolymer adjuvants appear to influence antibody isotype development, potentially via T-cell subsets.

Conclusions:

  • Nonionic block copolymers are effective adjuvants for enhancing antibody responses.
  • Certain formulations show potential for inducing protective immunity and may be suitable for clinical trials.
  • Further research is needed to optimize formulations for specific antigens and administration routes, including mucosal delivery.

Related Experiment Videos